The colorectal cancer market in South & Central America is expected to grow from US$ 681.70 million in 2022 to US$ 814.50 million by 2028; it is estimated to grow at a CAGR of 2.2% from 2022 to 2028.
The market for colorectal cancer in the region is expected to grow owing to rise in the incidences of colorectal cancer and increase in the demand for colonoscopy procedures in Brazil. The market is also attributed to grow in Argentina due to the rising advancement for the technology to prevent incidences of the cancers.
The Rest of South & Central America colorectal cancer market is segmented into Chile, Peru, Ecuador, and other countries. According to GLOBOCAN 2020 data, there were approximately 6,219 new colorectal cancer cases in Chile, representing 11.5% of all new cancer cases in both genders, and ~4,636 new colorectal cancer cases were diagnosed in all ages in Peru.
Moreover, the majority of the countries in Latin America lack adequate systematic screening or prevention programs. The general screening of people aged above 50 years is a cost-effective and efficacious way of reducing colorectal cancer. Several South & Central American countries have developed national guidelines for early detection, management, and follow-up of colorectal cancer. Further, Uruguay has implemented colorectal cancer screening programs, while Chile, Cuba, and Ecuador have initiated pilot studies.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South & Central America colorectal cancer market at a substantial CAGR during the forecast period.
South & Central America Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Colorectal Cancer Market Segmentation
The South & Central America colorectal cancer market is segmented into modality, and end user, and country. Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment holds the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the global colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment holds a larger market share. Based on country, the South & Central America colorectal cancer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America held the largest market share in 2022.
Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the South & Central America colorectal cancer market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 681.70 Million |
| Market Size by 2028 | US$ 814.50 Million |
| CAGR (2022 - 2028) | 2.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Modality
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Colorectal Cancer Market is valued at US$ 681.70 Million in 2022, it is projected to reach US$ 814.50 Million by 2028.
As per our report South & Central America Colorectal Cancer Market, the market size is valued at US$ 681.70 Million in 2022, projecting it to reach US$ 814.50 Million by 2028. This translates to a CAGR of approximately 2.2% during the forecast period.
The South & Central America Colorectal Cancer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Colorectal Cancer Market report:
The South & Central America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Colorectal Cancer Market
